Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease

Jeha Jeon, Young Cha, Yean Ju Hong, In‐Hee Lee, HeeJin Jang, Sanghyeok Ko, Serhiy Naumenko, Minseon Kim, Hannah L. Ryu, Zenith Shrestha, Nayeon Lee, Tae Yoon Park, H.-R. Park, Seohyun Kim, Ki‐Jun Yoon, Bin Song, Jeffrey S. Schweitzer, Todd M. Herrington, Sek Won Kong, Bob S. Carter, Pierre Leblanc, Kwang‐Soo Kim